HMI
  • About
    • Who we are?
    • Mission
    • Traditions & History
    • Partnerships
    • Advisory Council
    • Giving
      • Support the HMI now
        • Applied-Microbiology Programs
        • Disease-Specific Research Programs
        • Longevity and Aging Research Program
        • General support of HMI
      • Ways to give
      • Your impact
      • Naming opportunities
  • Research
    • Applied microbiology programs
      • Bacteriophages as New Human Viral Pathogens
      • Prion-like Domains in Eukaryotic Viruses
      • Novel bacterial species
      • The core human microbiome
      • Novel Bacterial Pathogens of Humans
      • Antimicrobial resistance | Sporobiota | Sporobiome
      • Regulators of the Microbiota (NLGE)
    • Disease-specific Research Programs
      • Parkinson’s disease
      • Alzheimer’s disease
      • Amyotrophic Lateral Sclerosis
      • Autism
      • Multiple sclerosis
      • Oncology
      • Type 1 Diabetes
      • Age-related Infectious Diseases
      • Antibiotic resistance/Novel Diagnostic Systems
      • Jewish Research
      • Other Focus Areas
    • Longevity and Aging Research Program
  • Therapeutic Areas
  • For Scientists
    • Theories Developed by the HMI
      • Microbiota diseases
      • The Pangenome concept
      • Tetz’s theory of longevity
      • Maternal Inheritance of the Microbiota
      • Neurodegenerative diseases theory
      • Genetic Predisposition in Jewish Population
    • HMI Database
      • Kluyvera intestini sp. nov. GT-16
      • Bacillus sp. VT 712
      • Acinetobacter sp. nov. VT-511
      • Bacilli bacteriumgen. nov. sp. nov. VT-13-104
      • Paenibacillus sp. nov. VT 400
      • Streptococcus sp. nov. VT 162
    • Publications
  • Education
  • Newsroom
    • News from the HMI
    • For Journalists
  • Contact

Other Focus Areas

HMI  is also conducting research within neurodegeneration, neuroplasticity and autoimmunity  where there is significant unmet medical need.

We welcome and appreciate your interest in HMI Therapeutic Area. We look forward to expand our research in these areas conducting next transformative step in medicine.

  • Disease-specific Research Programs
  • Parkinson’s disease
  • Alzheimer’s disease
  • Amyotrophic Lateral Sclerosis
  • Autism
  • Multiple sclerosis
  • Oncology
  • Type 1 Diabetes
  • Age-related Infectious Diseases
  • Antibiotic resistance/Novel Diagnostic Systems
  • Jewish Research
  • Other Focus Areas
  • Age-related cognitive diseases
  • Age-related infectious diseases
  • Metabolic disorders
  • Cancer research
  • Autism spectrum disorders
  • Novel human pathologies
    • New group of human viral diseases
    • Microbiota diseases
  • Novel diagnostic systems
  • Jewish Research
  • Microbiota of Genius’ individuals
  • Parkinson’s disease
  • Alzheimer’s disease
  • Amyotrophic Lateral Sclerosis
  • Autism
  • Multiple sclerosis
  • Oncology
  • Type 1 Diabetes
  • Age-related Infectious Diseases
  • Antibiotic resistance/Novel Diagnostic Systems
  • Jewish Research
  • Other Focus Areas
  • Age-related cognitive diseases
  • Age-related infectious diseases
  • Metabolic disorders
  • Cancer research
  • Autism spectrum disorders
  • Novel human pathologies
    • New group of human viral diseases
    • Microbiota diseases
  • Novel diagnostic systems
  • Jewish Research
  • Microbiota of Genius’ individuals
HMI
101 6th avenue, New York, NY, 10013 (at the JLabs)
Email: info@hmi-us.com
Monday — Friday 8:30 AM — 6:00 PM EST

All Rights Reserved.
Terms of Use | Privacy Policy
About
  • Who we are?
  • Mission
  • Traditions & History
  • Partnerships
  • Advisory Council
  • Giving
Research
  • Applied microbiology programs
  • Disease-specific Research Programs
  • Longevity and Aging Research Program
SCIENTIFIC COMMUNITY
  • Theories Developed by the HMI
  • HMI Database
  • Publications
EDUCATION
  • Education
NEWS
  • News from the HMI
Information
  • Contact with us
  • Privacy Policy
  • Terms of Use